Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO
· Real-Time Price · USD
0.27
-0.03 (-10.00%)
At close: May 23, 2025, 3:59 PM
0.27
0.11%
After-hours: May 23, 2025, 05:55 PM EDT
-10.00% (1D)
| Bid | 0.26 |
| Market Cap | 2.19M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -23.7M |
| EPS (ttm) | 276.44 |
| PE Ratio (ttm) | n/a |
| Forward PE | -0.03 |
| Analyst | Buy |
| Ask | 0.29 |
| Volume | 1,985,797 |
| Avg. Volume (20D) | 5,013,076 |
| Open | 0.28 |
| Previous Close | 0.30 |
| Day's Range | 0.26 - 0.29 |
| 52-Week Range | 0.24 - 32.93 |
| Beta | 6.06 |
About APVO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APVO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for APVO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 days ago
-21.05%
Aptevo Therapeutics shares are trading lower after...
Unlock content with
Pro Subscription
1 month ago
+44.2%
Aptevo Therapeutics shares are trading higher. The company announced a $2.1 million registered direct offering and private placement.
2 months ago · accessnewswire.com
RAINIER Trial Data Update: Two Additional AML Patients Achieve Remission Within 30 Days of TreatmentAcross two trials, 9 of 10 frontline AML patients achieved remission when treated with mipletamig in combination with the standard of care Triplet Combination with mipletamig continues to outperform d...
